Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Regeneron Pharmaceuticals (REGN) Q1 2022 Earnings
REGN
4
Feb
Confirmed
Q2 2021
Q3 2021
Q4 2021
Q1 2022
8.47
14.25
20.02
25.8
Details
Expected EPS
18.59
Actual EPS
21.32
Surprise EPS
2.73
Surprise Percent
+14.69%
Description
Regeneron Pharmaceuticals (REGN) has reported earnings of 21.32 per share for Q1 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login